The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice With Experimental Colitis
Journal of Clinical Immunology - United States
doi 10.1007/s10875-007-9074-2
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2007
Authors
Publisher
Springer Science and Business Media LLC